Cancer stem cells, EMT, and developmental pathway activation in pancreatic tumors

S Hindriksen, MF Bijlsma - Cancers, 2012 - mdpi.com
Pancreatic cancer is a disease with remarkably poor patient survival rates. The frequent
presence of metastases and profound chemoresistance pose a severe problem for the …

[HTML][HTML] Pancreatic cancer growth promoted by bone marrow mesenchymal stromal cell–derived IL-6 is reversed predominantly by IL-6 blockade

R Antoon, XH Wang, AH Saleh, J Warrington… - Cytotherapy, 2022 - Elsevier
Pancreatic cancer is a highly lethal cancer characterized by local invasiveness, early
metastasis, recurrence and high resistance to current therapies. Extensive stroma or …

Targeting c-MET in gastrointestinal tumours: rationale, opportunities and challenges

CA Bradley, M Salto-Tellez, P Laurent-Puig… - Nature reviews Clinical …, 2017 - nature.com
Data from many preclinical studies, including those using cellular models of colorectal,
gastric, gastro-oesophageal and gastro-oesophageal junction cancers, indicate that the …

HGF/c-MET targeted therapeutics: novel strategies for cancer medicine

TA Yap, SK Sandhu, SM Alam… - Current drug …, 2011 - ingentaconnect.com
The hepatocyte growth factor/mesenchymal-epithelial transition factor (HGF/c-MET) receptor
tyrosine kinase (RTK) pathway plays a pleotropic role in cell proliferation, migration …

Pancreatic cancer microenvironment: a current dilemma

B Uzunparmak, IH Sahin - Clinical and translational medicine, 2019 - Springer
Pancreatic cancer is one of the leading causes of cancer-related death in the United States
and survival outcomes remain dismal despite significant advances in molecular diagnostics …

Regulators of epithelial mesenchymal transition in pancreatic cancer

S Hamada, K Satoh, A Masamune… - Frontiers in …, 2012 - frontiersin.org
Pancreatic cancer is a leading cause of cancer-related death due to its invasive nature.
Despite the improvement of diagnostic strategy, early diagnosis of pancreatic cancer is still …

The role of stromal components in pancreatic cancer progression

M Xu, BP Zhou, M Tao, J Liu… - Anti-Cancer Agents in …, 2016 - ingentaconnect.com
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal human cancers, and is
known for its extremely poor prognosis. Because of the location and composition of the …

Targeting the hepatocyte growth factor/mesenchymal epithelial transition pathway in gastric cancer: biological rationale and clinical applications

O Abdel-Rahman - Expert Review of Anticancer Therapy, 2015 - Taylor & Francis
Advanced gastric cancer (GC) is a dreadful disease with a poor prognosis and the majority
of patients die within 1 year of diagnosis. In the past decade, important signaling pathways …

Alteration of pancreatic cancer cell functions by tumor-stromal cell interaction

S Hamada, A Masamune, T Shimosegawa - Frontiers in physiology, 2013 - frontiersin.org
Pancreatic cancer shows a characteristic tissue structure called desmoplasia, which consists
of dense fibrotic stroma surrounding cancer cells. Interactions between pancreatic cancer …

Cholecystokinin receptor antagonist induces pancreatic stellate cell plasticity rendering the tumor microenvironment less oncogenic

G Jolly, T Duka, N Shivapurkar, W Chen, S Bansal… - Cancers, 2023 - mdpi.com
Simple Summary The tumor microenvironment of pancreatic cancer consists of dense
fibrotic stroma, which, to a certain extent, accounts for the relative drug resistance of this …